Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vicky Makker

Showing results (31-40 of 140) with videos related to

Pageof 14
Sort By:
Gynecologic Oncology|January 1, 2013
Placental site trophoblastic tumor: analysis of presentation, treatment, and outcomeDavid M Hyman, Lauren Bakios, Gina Gualtiere, et al.
Gynecologic Oncology|September 24, 2013
Patterns of relapse in stage I-II uterine papillary serous carcinoma treated with adjuvant intravaginal radiation (IVRT) with or without chemotherapyNeil B Desai, Ana P Kiess, Marisa A Kollmeier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2018
Phase Ib Study of Binimetinib with Paclitaxel in Patients with Platinum-Resistant Ovarian Cancer: Final Results, Potential Biomarkers, and Extreme RespondersRachel N Grisham, Kathleen N Moore, Michael S Gordon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 1, 2013
Treatment outcomes in completely resected stage I to stage IV uterine carcinosarcoma with rhabdomyosarcoma differentiationVicky Makker, Sara J Kravetz, Jacqueline Gallagher, et al.
The Oncologist|June 30, 2021
Characterization and Management of Adverse Reactions in Patients with Advanced Endometrial Carcinoma Treated with Lenvatinib Plus PembrolizumabVicky Makker, Matthew H Taylor, Ana Oaknin, et al.
Gynecologic Oncology Reports|November 15, 2018
Brain metastases in patients with low-grade endometrial carcinomaPaulina Cybulska, Marina Stasenko, Raanan Alter, et al.
Gynecologic Oncology|November 20, 2012
Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancerMichael R Folkert, Karin K Shih, Nadeem R Abu-Rustum, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 30, 2025
Prognostic value of "aggressive" histology in surgically staged clinically uterine-confined endometrial carcinomaChristian Dagher, Jennifer J Mueller, Yukio Sonoda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2020
Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid TumorsMatthew H Taylor, Chung-Han Lee, Vicky Makker, et al.
Brachytherapy|October 15, 2018
Comparison of outcomes in early-stage uterine clear cell carcinoma and serous carcinomaMinsi Zhang, T Jonathan Yang, Neil B Desai, et al.
Pageof 14

Showing results (31-40 of 140) with videos related to

Sort By:
Pageof 14
Gynecologic Oncology|January 1, 2013
Placental site trophoblastic tumor: analysis of presentation, treatment, and outcomeDavid M Hyman, Lauren Bakios, Gina Gualtiere, et al.
Gynecologic Oncology|September 24, 2013
Patterns of relapse in stage I-II uterine papillary serous carcinoma treated with adjuvant intravaginal radiation (IVRT) with or without chemotherapyNeil B Desai, Ana P Kiess, Marisa A Kollmeier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2018
Phase Ib Study of Binimetinib with Paclitaxel in Patients with Platinum-Resistant Ovarian Cancer: Final Results, Potential Biomarkers, and Extreme RespondersRachel N Grisham, Kathleen N Moore, Michael S Gordon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 1, 2013
Treatment outcomes in completely resected stage I to stage IV uterine carcinosarcoma with rhabdomyosarcoma differentiationVicky Makker, Sara J Kravetz, Jacqueline Gallagher, et al.
The Oncologist|June 30, 2021
Characterization and Management of Adverse Reactions in Patients with Advanced Endometrial Carcinoma Treated with Lenvatinib Plus PembrolizumabVicky Makker, Matthew H Taylor, Ana Oaknin, et al.
Gynecologic Oncology Reports|November 15, 2018
Brain metastases in patients with low-grade endometrial carcinomaPaulina Cybulska, Marina Stasenko, Raanan Alter, et al.
Gynecologic Oncology|November 20, 2012
Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancerMichael R Folkert, Karin K Shih, Nadeem R Abu-Rustum, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 30, 2025
Prognostic value of "aggressive" histology in surgically staged clinically uterine-confined endometrial carcinomaChristian Dagher, Jennifer J Mueller, Yukio Sonoda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2020
Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid TumorsMatthew H Taylor, Chung-Han Lee, Vicky Makker, et al.
Brachytherapy|October 15, 2018
Comparison of outcomes in early-stage uterine clear cell carcinoma and serous carcinomaMinsi Zhang, T Jonathan Yang, Neil B Desai, et al.
Pageof 14